⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Neurofilament Light Chain (NfL) as Aging Biomarker
Current understanding
Blood neurofilament light chain (NfL) is a circulating marker of axonal injury increasingly studied as a general aging and neurodegeneration readout in older adults. Cross-sectional human observational evidence [human-observational] links higher NfL to lower WHO intrinsic capacity independent of age and comorbidity, with partial mediation of inflammatory protein signals (CXCL9, TNFRSF11B). Whether NfL tracks decline longitudinally or moves with interventions in non-disease aging cohorts is not established.
Evidence log
- 2026-09-28 — Epigenetic age acceleration is associated with brain connectivity changes and the risk of major depression after trauma: cross-connection with epigenetic-clocks: Post-trauma epigenetic age acceleration joins NfL as a peripherally measurable aging biomarker associated with downstream brain and psychiatric endpoints, offering a potential multi-marker acute-injury stratification layer. (novelty: 3)
- 2026-08-02 — Brain aging clocks: From methodological advances to cellular mechanisms.: Methodological review of brain aging clocks situates fluid axonal-injury markers (including NfL) as a complementary layer to imaging and cellular brain clocks for earlier detection of neurodegenerative trajectories; narrative synthesis, no new NfL cohort data. [expert-opinion] (novelty: 3)
- 2025-12-15 — Sensorimotor function as an early marker of cognitive decline and alzheimer’s biomarker burden.: Prospective observational study in cognitively normal older adults reports plasma NfL co-varies with slower gait speed, concordant with CSF tau/Aβ burden — adds direct cross-sectional pairing of a bedside functional marker with a blood axonal-injury signal in a non-disease cohort. [human-observational] (novelty: 3)
- 2026-09-12 — The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.: cross-connection with cis-p-tau-biomarker: Both are proposed as early, cross-etiology neuronal-injury biomarkers spanning neurodegenerative, traumatic, and vascular contexts; the review positions cis P-tau as an upstream tau-specific complement to NfL’s non-specific axonal damage signal. (novelty: 3)
- 2026-09-26 — Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.: Rhesus macaque CSF/plasma proteomics report age-related neurosenescence and neuropathology signatures with human-overlapping markers, situating NfL-adjacent axonal/CNS-aging proteins in a compartment-specific NHP framework — preclinical context for blood vs CSF interpretation, no direct NfL longitudinal data. [animal-model] (novelty: 3)
- 2026-09-19 — Alzheimer’s disease biomarkers in relation to non-cognitive domains within the intrinsic capacity framework: a narrative review.: Narrative review positions NfL alongside Aβ, tau, GFAP and neuroimaging as an AD-related biomarker whose elevations track with non-cognitive intrinsic-capacity deficits (locomotion, grip, depression, hearing) across 119 human studies — consistent with NfL’s cross-sectional IC association but still non-causal. [human-observational] (novelty: 3)
- 2026-07-13 — #399 ‒ The evolution of Alzheimer’s disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.: cross-connection with alzheimers-early-detection: Blood-based NfL is one of the emerging biomarkers underpinning the earlier-diagnosis window that clinicians like Devi are acting on. (novelty: 3)
- 2026-08-13 — The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts.: cross-connection with epigenetic-clocks: DNAmFitAge acceleration with concussion count and blood NfL as axonal-injury marker converge as candidate biomarkers of repetitive head-impact aging, but the two layers have not been co-measured in the same contact-sport cohorts. (novelty: 3)
- 2026-08-04 — Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.: cross-connection with brain-age-neuroimaging: NfL is a blood-based axonal-injury signal that plausibly overlaps with imaging-derived brain-age gap; both target CNS aging from different measurement layers and have not been jointly validated in the same cohorts. (novelty: 3)
Open questions
Related
Contributing findings
Plasma biomarkers of neurodegeneration and physical performance in older adults.
14-oct-2026
novelty 2
per-area 2
weakens
Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.
26-sep-2026
novelty 3
per-area 3
strengthens
Alzheimer's disease biomarkers in relation to non-cognitive domains within the intrinsic capacity framework: a narrative review.
19-sep-2026
novelty 3
per-area 3
strengthens
The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts.
13-aug-2026
novelty 3
per-area 1
mentions
Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.
04-aug-2026
novelty 3
per-area 3
introduces
Brain aging clocks: From methodological advances to cellular mechanisms.
02-aug-2026
novelty 3
per-area 3
strengthens
Sensorimotor function as an early marker of cognitive decline and alzheimer's biomarker burden.
15-dec-2025
novelty 3
per-area 3
strengthens